Category Archives: AZBio News
This Fast Lane Company is Saving Lives One Heart at a Time
A vital lifeline to patients facing end-stage biventricular heart failure.
For millions of people worldwide, cardiac health is something taken for granted—a steady, rhythmic beat keeping life in motion. But for patients diagnosed with advanced biventricular heart failure, that rhythm slows to a dangerous point. When both the left and right ventricles can no longer pump enough blood to sustain vital organs, the threat of imminent death becomes an immediate reality.
In these critical moments, modern medical technology steps in with a groundbreaking solution: the SynCardia Total Artificial Heart (STAH)Continue reading
He learned to be a scientist as a teenager. Now he seeks a cure for a childhood cancer.
He learned to be a scientist as a teenager. Now he seeks a cure for a childhood cancerContinue reading
Alzheimer’s research pioneer announces leadership transition after 38 years at Banner Health
Dr. Eric M. Reiman’s groundbreaking work transformed Alzheimer’s research and positioned Banner as a global leader in detection, prevention studiesContinue reading
Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform
Federal funding backs engineering to advance the wireless and radio-frequency systems for the wearable toward manufacturing at scale, in partnership with the University of ArizonaContinue reading
Precision Epigenomics Named an AZBio Fast Lane Company
Detecting Cancer Before It Starts: How One Arizona Startup Is Transforming Precision Oncology
In modern medicine, early cancer detection remains a central goal. Identifying a tumor before symptoms emerge often makes the difference between routine intervention and a terminal diagnosis.
Standing at the leading edge of this shift is Precision Epigenomics, a Tucson-based bioscience startup whose rapid trajectory over the past 18 months is drawing national attention. Through cutting-edge liquid biopsy technology, rigorous laboratory standards, and high-impact strategic partnerships, the company is turning complex epigenetic science into life-saving clinical tools.Continue reading
Evidence Matters: Navigating the 2026–2027 Respiratory Virus Season
As Arizona enters another respiratory virus season, physicians will once again navigate patient questions surrounding influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) immunization. In an environment of evolving recommendations and competing information, access to rigorous, transparent evidence is essential to informed clinical decision-making.Continue reading
C-Path Mourns the Passing of Board Member Peter Barton Hutt
TUCSON, Ariz., September 3, 2026 — Critical Path Institute® (C-Path) is deeply saddened to announce the passing of Peter Barton Hutt, a longtime member of C-Path’s Board of Directors, on September 2, 2026.Continue reading
AZBio offers ASU tuition scholarships to Member employees and dependents
Employees of AZBio Member Companies and their dependents can now get a 15% scholarship for over 400 undergraduate degrees, graduate degrees, and certificates offered by ASU Online.
Learn more at AZBio.org/InStrideContinue reading
Bright Path Labs Moves into the Fast Lane
Bright Path is Transforming America’s Access to Essential Medicines..
Bright Path will be honored with an AZBio Fast Lane Award on Oct. 7, 2026 at the Phoenix Convention Center at the 23 annual AZBio Awards.Continue reading